Administration of the tetrapeptide cholecystokinin (CCK-4) has been shown to induce panic attacks in both patients with panic disorder and healthy volunteers, suggesting a direct effect of CCK on the mechanisms of anxiety [47]. This evidence concerns the gene PTK7 and panic disorder.